Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
0.40 Down 0.01(2.37%) Aug 28, 4:00PM EDT
Add to Portfolio
Prev Close:0.41
Open:0.39
Bid:0.37 x 300
Ask:0.64 x 300
1y Target Est:1.30
Beta:0.707955
Earnings Date:Nov 3 - Nov 9 (Est.)
Day's Range:0.39 - 0.42
52wk Range:0.36 - 2.78
Volume:207,088
Avg Vol (3m):561,240
Market Cap:8.71M
P/E (ttm):N/A
EPS (ttm):-1.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHDown 2.37%8.71M
LLYDown 0.66%88.10B
PFEDown 1.80%201.43B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback